BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16255692)

  • 1. Retinitis pigmentosa: visual function and multidisciplinary management.
    Herse P
    Clin Exp Optom; 2005 Sep; 88(5):335-50. PubMed ID: 16255692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
    Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
    Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sector retinitis pigmentosa.
    Van Woerkom C; Ferrucci S
    Optometry; 2005 May; 76(5):309-17. PubMed ID: 15884421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.
    Arslan U; Özmert E; Demirel S; Örnek F; Şermet F
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):893-908. PubMed ID: 29546474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of vision loss with tactile-evoked V1 responses in retinitis pigmentosa.
    Cunningham SI; Weiland JD; Bao P; Lopez-Jaime GR; Tjan BS
    Vision Res; 2015 Jun; 111(Pt B):197-207. PubMed ID: 25449160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VISUAL IMPAIRMENT IN RETINITIS PIGMENTOSA.
    Vezinaw CM; Fishman GA; McAnany JJ
    Retina; 2020 Aug; 40(8):1630-1633. PubMed ID: 31568063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term follow-up of deterioration of the visual field in visual acuity in retinitis pigmentosa].
    Schmidt JG; Zinser J
    Fortschr Ophthalmol; 1989; 86(6):614-8. PubMed ID: 2625290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical expression of X-linked retinitis pigmentosa in a Swedish family with the RP2 genotype.
    Ponjavic V; Andréasson S; Abrahamson M; Ehinger B; Gieser L; Fujita R; Swaroop A
    Ophthalmic Genet; 1998 Dec; 19(4):187-96. PubMed ID: 9895243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobility of people with retinitis pigmentosa as a function of vision and psychological variables.
    Haymes S; Guest D; Heyes A; Johnston A
    Optom Vis Sci; 1996 Oct; 73(10):621-37. PubMed ID: 8916133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual acuity impairment in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Alexander KR; Anderson RJ; Derlacki DJ
    Ophthalmology; 1996 Oct; 103(10):1593-600. PubMed ID: 8874431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Night-vision aid using see-through display for patients with retinitis pigmentosa.
    Ikeda Y; Nakatake S; Funatsu J; Fujiwara K; Tachibana T; Murakami Y; Hisatomi T; Yoshida S; Enaida H; Ishibashi T; Sonoda KH
    Jpn J Ophthalmol; 2019 Mar; 63(2):181-185. PubMed ID: 30604110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between difficulty in performing daily activities and clinical measures of visual function in patients with retinitis pigmentosa.
    Szlyk JP; Fishman GA; Alexander KR; Revelins BI; Derlacki DJ; Anderson RJ
    Arch Ophthalmol; 1997 Jan; 115(1):53-9. PubMed ID: 9006425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual field expansion in patients with retinitis pigmentosa.
    Somani S; Brent MH; Markowitz SN
    Can J Ophthalmol; 2006 Feb; 41(1):27-33. PubMed ID: 16462868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual acuity with the ITT Night Vision Aid for patients with night blindness.
    Hoover KL
    Am J Optom Physiol Opt; 1983 Sep; 60(9):762-8. PubMed ID: 6336139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.
    Vingolo EM; Rocco M; Grenga P; Salvatore S; Pelaia P
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):93-8. PubMed ID: 17674017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulties With Goals of the Dutch ICF Activity Inventory: Perceptions of Those With Retinitis Pigmentosa and of Those Who Support Them.
    Latham K; Baranian M; Timmis MA; Pardhan S
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2381-91. PubMed ID: 25766586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts.
    Virgili G; Pierrottet C; Parmeggiani F; Pennino M; Giacomelli G; Steindler P; Menchini U; Orzalesi N;
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3418-24. PubMed ID: 15452044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Central Retinal Artery Blood Flow Is Related to Impaired Central Visual Function in Retinitis Pigmentosa Patients.
    Kayser S; Vargas P; Mendelsohn D; Han J; Bi H; Benavente A; Bittner AK
    Curr Eye Res; 2017 Nov; 42(11):1503-1510. PubMed ID: 28910168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMPG2-associated retinitis pigmentosa displays relatively early macular involvement.
    van Huet RA; Collin RW; Siemiatkowska AM; Klaver CC; Hoyng CB; Simonelli F; Khan MI; Qamar R; Banin E; Cremers FP; Theelen T; den Hollander AI; van den Born LI; Klevering BJ
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3939-53. PubMed ID: 24876279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.